Traveling executives, busy managers and out-of-office workers will no longer be
a burden to efficient accounts payable and other financial processes thanks to a
new step in mobile business process automation from ReadSoft.
ReadSoft, a global provider of applications for automating business processes,
is proud to announce the release of the ReadSoft Mobile app for iOS, Android,
BlackBerry and Windows 8 mobile operating systems.
The mobile app allows users of ReadSoft automation solutions to conne
WALTHAM, Mass., Dec. 10, 2013 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) announced today that the Centers for Medicare and Medicaid Services (CMS) have published the final determination of the 2014 Medicare national limitation amount for the Company's galectin-3 blood test (analyte-specific CPT® Code 82777) at the amount of a crosswalked test (analyte-specific CPT® Code 84244) whose 2014 national limitation amount is $30.01. This national limitation amount will replace the galectin-3 blood test's national limitation amount of $17.80 that was effective in 2013.
MITCHEL FIELD, N.Y., Dec. 10, 2013 (GLOBE NEWSWIRE) -- Frequency Electronics, Inc. (Nasdaq:FEIM), will hold its quarterly conference call to discuss results for the second quarter of fiscal year 2014, ended October 31, 2013, on Wednesday, December 11, 2013, at 3:00 PM Eastern Time.
Chefer som är upptagna, på tjänsteresa och anställda som inte är på kontoret
(”out-of-office”) är inte längre något hinder för att kunna ha en effektiv
hantering av fakturor eller andra finansiella processer. Detta tack vare en nytt
steg inom mobil hantering och automatisering av affärsprocesser från Readsoft.
ReadSoft, en ledande global leverantör av applikationer för att automatisera
affärsprocesser, meddelar idag lanseringen av ReadSofts mobilappar för iOS,
Android, BlackBerry och Windows 8 m
HAMPTON, N.J., Dec. 10, 2013 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (Nasdaq:CLDX) announced today positive results from a preclinical combination study of CDX-301 (FMS-like tyrosine kinase-3 ligand or Flt3L) and Mozobil
TROY, Mich., Dec. 10, 2013 (GLOBE NEWSWIRE) -- Syntel, Inc. (Nasdaq:SYNT), a global information technology services and Knowledge Process Outsourcing (KPO) firm, today announced it has inaugurated a new development center in suburban Baltimore, Maryland to expand the Company's capacity to deliver solutions for its clients.
SAN DIEGO, Dec. 10, 2013 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing and commercializing products for the treatment of central nervous system (CNS) disorders and pain, announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for a 4 mg dose of SUMAVEL DosePro (sumatriptan injection) Needle-free Delivery System. SUMAVEL DosePro has been available in a 6 mg dose for the treatment of acute migraine and cluster headache. The 4 mg dose of SUMAVEL DosePro can be used to help migraine sufferers who require management of side effects. The 4 mg dose of SUMAVEL DosePro is expected to be available approximately June 2014.
FORT LAUDERDALE, Fla., Dec. 10, 2013 (GLOBE NEWSWIRE) -- JDL Technologies today announced it is providing additional support for the Florida Student Astronaut Challenge, joining NASA and Coaxis International as a premier Mission Control Sponsor. In October, JDL Technologies employees helped proctor the regional exams, in which 55 Florida high school teams participated.
GlobeNewswire, a NASDAQ OMX company, is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.